Cystatin C Assay Market Size & Share 2024 to 2032
Market Size by Product (Kits, Reagents, Analyzers), by Sample Type (Blood, Urine), by Method (ELISA, PETIA, PENIA, CLIA, Immunofluorescence Assay), by Application, End use & Forecast.
Report ID: GMI7697
|
Published Date: December 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Cystatin C Assay Market Size
Cystatin C Assay Market was valued at USD 269.6 million in 2023 and is anticipated to grow at a CAGR of over 7.7% between 2024 & 2032. A cystatin C assay is a laboratory test designed to measure the concentration of cystatin C in biological samples, typically in blood or serum. It is commonly used as a biomarker for estimating glomerular filtration rate (GFR). The assays play a vital role in the early diagnosis, monitoring, and kidney stone management, contributing to improved patient outcomes and driving innovation in the field of renal function assessment.
Cystatin C Assay Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The increasing prevalence of chronic kidney diseases is anticipated to augment the cystatin C assay market. According to the report published by the Centers for Disease Control and Prevention (CDC) in 2022, more than 1 in 7 U.S. adults, about 14% or an estimated 37 million people are affected by CKD. Thus, as the incidence of chronic kidney diseases increases globally the demand for effective diagnostic solutions to measure the concentration of cystatin C, stimulating market growth.
Cystatin C Assay Market Trends
The increasing geriatric population has created a larger pool of individuals at risk of kidney-related issues, making reliable and accurate renal function assessments crucial. For instance, according to the World Health Organization (WHO) estimates, the global population of individuals aged 60 years and above is anticipated to increase from 1 billion in 2020 to 1.4 billion by 2040. Cystatin C assays offer a valuable solution contributing to the growth of the market for assessing kidney function particularly in the elderly population. Additionally, advances in diagnostic technologies, such as point-of-care testing, are making cystatin C assays more accessible and convenient, ultimately improving patient care and helping clinicians make informed decisions about renal health among elderly population.
Cystatin C Assay Market Analysis
The cystatin C assay industry by product is categorized into kits, reagents, and analyzers. The kits segment garnered USD 116.8 million revenue size in the year 2023 and is projected to have the fastest-growing CAGR in the forecast period.
Therefore, the increasing preference for these kits will play a pivotal role in propelling the market growth.
Based on sample type, the market is segmented into blood and urine. Blood segment garnered USD 183.9 million revenue size in 2023.
Based on method, the market is segmented into enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), particle-enhanced nephelometric immunoassay (PENIA), chemiluminescent immunoassay (CLIA), immunofluorescence assay, and other methods. Enzyme-linked immunosorbent assay (ELISA) segment garnered USD 78.8 million revenue in 2023.
Thus, its high sensitivity and specificity, quantitative capabilities, ease of use, adaptability to automation, cost-effectiveness, and widespread acceptance in both research and clinical settings is anticipated to boost demand for enzyme-linked immunosorbent assay (ELISA) method.
Based on application, the market is segmented into diagnostics and research. The diagnostics segment held substantial revenue in the market accounting for USD 192 million in the year 2023.
Based on end-use, the cystatin C assay market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, and other end-users. The hospital segment accounted for largest share of 32.3% in 2023 in the market. The large share of this segment can be attributed to large patient pool and easy access. Hospitals adhere to stringent quality control and assurance standards when conducting cystatin C assays. This ensures the accuracy and reliability of test results, meeting regulatory requirements.
The U.S. market accounted for USD 102.4 million revenue size in 2023 and is predicted to witness substantial market growth over the analysis timeline.
Cystatin C Assay Market Share
The cystatin C assay industry is consolidated, with key players including, Roche Diagnostics Limited, Siemens Healthineers AG, Abbott Laboratories, Beckman Coulter (Danaher Corporation), and others dominating the market space. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, in January 2021, Roche acquired GenMark, which is involved in the development and manufacturing of cystatin C assays. This acquisition strengthened Roche's position in the cystatin C assay industry and expanded its product portfolio.
Cystatin C Assay Market Companies
Some of the eminent market participants operating in the cystatin C assay industry include:
Cystatin C Assay Industry News
Cystatin C assay market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Sample Type
Market, By Method
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →